Aarti Pharmalabs share price
You have to be logged in to add this to Watchlist.- ₹793.05(3.42%)January 14, 2026 15:50:09 PM IST
- NSE
- BSE
- Vol : 517.22 K (NSE + BSE)Last 20 day avg : 222.29 K
Aarti Pharmalabs is trading 3.42% upper at Rs 793.05 as compared to its last closing price. Aarti Pharmalabs has been trading in the price range of 805.55 & 761.60. Aarti Pharmalabs has given 1.63% in this year & 3.77% in the last 5 days. Aarti Pharmalabs has TTM P/E ratio 31.29 as compared to the sector P/E of 22.79.The company posted a net profit of 27.92 Crores in its last quarter.Listed peers of Aarti Pharmalabs include Sun Pharmaceutical Industries (-1.69%), Dr Reddy's Laboratories (-0.22%), Divi's Laboratories (-1.29%).The Mutual Fund holding in Aarti Pharmalabs was at 0.79% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Aarti Pharmalabs was at 8.02% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 15, 2026, 03:37 AM UTC
- Debt To EquityHigher than industry0.21The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.65Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.94The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Neutral | 1,700.55 | -1.69 | 4,08,009.30 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Bearish | 1,187.70 | -0.22 | 99,020.09 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Neutral | 6,350.50 | -1.29 | 1,68,751.74 | 78.61 | 11.52 | 0.46 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,003.25 | 1.62 | 1,35,536.88 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Bearish | 1,434.60 | -0.90 | 1,15,882.94 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-09 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-10 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results, Dividend & Others |
| 2024-10-28 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE0LRU01027
- BSE Code543748
- NSE CodeAARTIPHARM
Aarti Pharmalabs is trading at 793.05 as on Wed Jan 14 2026 10:20:09. This is 3.42% upper as compared to its previous closing price of 766.80.
The market capitalization of Aarti Pharmalabs is 7188.78 Cr as on Wed Jan 14 2026 10:20:09.
The 52 wk high for Aarti Pharmalabs is 971.50 whereas the 52 wk low is 557.20
Aarti Pharmalabs can be analyzed on the following key metrics -
- TTM P/E: 31.29
- Sector P/E: 22.79
- Dividend Yield: 0.65%
- D/E ratio: 0.32
Aarti Pharmalabs reported a net profit of 272.40 Cr in 2025.
The Mutual Fund Shareholding was 0.79% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Aarti Pharmalabs QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.